These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35335849)

  • 1. A Dual-Reporter Platform for Screening Tumor-Targeted Extracellular Vesicles.
    Kanada M; Linenfelser L; Cox E; Gilad AA
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Analysis of Heterogeneous Extracellular Vesicles Using a Red-Shifted Bioluminescence Resonance Energy Transfer Reporter Protein.
    Perez GI; Bachmann MH; Kanada M
    Methods Mol Biol; 2023; 2668():23-32. PubMed ID: 37140787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro and In Vivo Analysis of Extracellular Vesicle-Mediated Metastasis Using a Bright, Red-Shifted Bioluminescent Reporter Protein.
    Perez GI; Broadbent D; Zarea AA; Dolgikh B; Bernard MP; Withrow A; McGill A; Toomajian V; Thampy LK; Harkema J; Walker JR; Kirkland TA; Bachmann MH; Schmidt J; Kanada M
    Adv Genet (Hoboken); 2022 Mar; 3(1):2100055. PubMed ID: 36619349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and Evaluation of Engineered Extracellular Vesicle (EV)-Based Targeting for EGFR-Overexpressing Tumor Cells Using Monobody Display.
    Komuro H; Aminova S; Lauro K; Woldring D; Harada M
    Bioengineering (Basel); 2022 Jan; 9(2):. PubMed ID: 35200409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display.
    Antes TJ; Middleton RC; Luther KM; Ijichi T; Peck KA; Liu WJ; Valle J; Echavez AK; Marbán E
    J Nanobiotechnology; 2018 Aug; 16(1):61. PubMed ID: 30165851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Evaluation of Factors Affecting Extracellular Vesicle Uptake by Breast Cancer Cells.
    Stranford DM; Hung ME; Gargus ES; Shah RN; Leonard JN
    Tissue Eng Part A; 2017 Nov; 23(21-22):1274-1282. PubMed ID: 28586292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular Uptake of Engineered Extracellular Vesicles: Biomechanisms, Engineered Strategies, and Disease Treatment.
    Xie Q; Hao Y; Li N; Song H; Chen X; Zhou Z; Wang J; Zhang Y; Li H; Han P; Wang X
    Adv Healthc Mater; 2024 Jan; 13(2):e2302280. PubMed ID: 37812035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy.
    Jayasinghe MK; Pirisinu M; Yang Y; Peng B; Pham TT; Lee CY; Tan M; Vu LT; Dang XT; Pham TC; Chen H; Leung AYH; Cho WC; Shi J; Le MT
    Theranostics; 2022; 12(7):3288-3315. PubMed ID: 35547755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface display of functional moieties on extracellular vesicles using lipid anchors.
    Zheng W; Schürz M; Wiklander RJ; Gustafsson O; Gupta D; Slovak R; Traista A; Coluzzi A; Roudi S; Barone A; Farcas D; Kyriakopoulou E; Galli V; Sharma H; Meisner-Kober N; Honcharenko M; Andaloussi SEL
    J Control Release; 2023 May; 357():630-640. PubMed ID: 37084890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the conjugation efficiency of surface-modified extracellular vesicles using single nanovesicle analysis technologies.
    Goldbloom-Helzner L; Bains H; Loll EG; Henson T; Mizenko RR; Kumar P; Tan C; Farmer DL; Carney RP; Wang A
    Nanoscale; 2024 Sep; ():. PubMed ID: 39310954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting.
    Kooijmans SA; Aleza CG; Roffler SR; van Solinge WW; Vader P; Schiffelers RM
    J Extracell Vesicles; 2016; 5():31053. PubMed ID: 26979463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically Engineered Extracellular Vesicles Harboring Transmembrane Scaffolds Exhibit Differences in Their Size, Expression Levels of Specific Surface Markers and Cell-Uptake.
    Zhang J; Brown A; Johnson B; Diebold D; Asano K; Marriott G; Lu B
    Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining tropism and activity of natural and engineered extracellular vesicles.
    Choi W; Park DJ; Eliceiri BP
    Front Immunol; 2024; 15():1363185. PubMed ID: 38660297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery.
    Hung ME; Leonard JN
    J Extracell Vesicles; 2016; 5():31027. PubMed ID: 27189348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach.
    Kooijmans SAA; Gitz-Francois JJJM; Schiffelers RM; Vader P
    Nanoscale; 2018 Feb; 10(5):2413-2426. PubMed ID: 29334397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicle Uptake Assay via Confocal Microscope Imaging Analysis.
    Kim CJ; Kuczler MD; Dong L; Kim J; Amend SR; Cho YK; Pienta KJ
    J Vis Exp; 2022 Feb; (180):. PubMed ID: 35225262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering strategies for customizing extracellular vesicle uptake in a therapeutic context.
    Esmaeili A; Alini M; Baghaban Eslaminejad M; Hosseini S
    Stem Cell Res Ther; 2022 Mar; 13(1):129. PubMed ID: 35346367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells.
    Takenaka T; Nakai S; Katayama M; Hirano M; Ueno N; Noguchi K; Takatani-Nakase T; Fujii I; Kobayashi SS; Nakase I
    Int J Pharm; 2019 Dec; 572():118762. PubMed ID: 31610280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new bioluminescent reporter system to study the biodistribution of systematically injected tumor-derived bioluminescent extracellular vesicles in mice.
    Gangadaran P; Li XJ; Lee HW; Oh JM; Kalimuthu S; Rajendran RL; Son SH; Baek SH; Singh TD; Zhu L; Jeong SY; Lee SW; Lee J; Ahn BC
    Oncotarget; 2017 Dec; 8(66):109894-109914. PubMed ID: 29299117
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering.
    Alharbi M; Lai A; Godbole N; Guanzon D; Nair S; Zuñiga F; Quinn A; Yang M; Wu SY; Salomon C
    Int J Cancer; 2024 Oct; 155(8):1510-1523. PubMed ID: 38848494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.